Please check your internet connection and try again.
# Hyoscine butylbromide (Buscopan)
## Overview
Hyoscine butylbromide is an anticholinergic medication that acts as a smooth muscle relaxant, primarily affecting the gastrointestinal and genitourinary tracts. It works by blocking muscarinic acetylcholine receptors.
## Primary Indications
* Treatment of symptomatic relief of acute painful spasms of the hollow abdominal organs (e.g., gastrointestinal tract, biliary tract, urinary tract).
## Adult Dosing
* **Oral:** 20 mg four times daily. Maximum daily dose is not established but typically not to exceed 100 mg.
* **Intramuscular/Intravenous:** 20 mg every 8 hours as needed. Doses can be increased to 40 mg every 8 hours if necessary and tolerated. Continuous infusion is also used in some settings. Local protocol should be consulted for specific IV/IM dosing and infusion rates.
## Pediatric Dosing
* **Oral:** 10 mg three times daily for children aged 6 to 12 years. Data for younger children is limited.
* **Intramuscular/Intravenous:** Dosing in pediatrics is less established. Typically, 0.3-0.4 mg/kg per dose, up to a maximum of 20 mg per dose, every 8 hours. Safety and efficacy data for IV/IM use in very young children may be limited.
## Dose Adjustments
No specific dose adjustments are generally required for hepatic or renal impairment, as systemic absorption is variable and metabolism is primarily hepatic with minimal renal excretion. However, caution is advised in severe liver or kidney disease.
## Contraindications
* Hypersensitivity to hyoscine butylbromide or any component of the formulation.
* Myasthenia gravis.
* Gastrointestinal obstruction or ileus.
* Tachyarrhythmias.
* Narrow-angle glaucoma (contraindicated for parenteral administration, relative contraindication for oral).
* Benign prostatic hyperplasia with urinary retention.
* Megacolon.
* Post-surgical abdominal conditions where inhibition of peristalsis could be detrimental.
## Adverse Effects
Common adverse effects include dry mouth, blurred vision, tachycardia, urinary retention, constipation, and drowsiness. Less common but serious effects include anaphylactic reactions, especially with parenteral administration.
## Key Drug Interactions
* **Other Anticholinergics (e.g., tricyclic antidepressants, antihistamines, antiparkinsonian drugs):** May potentiate antimuscarinic side effects (dry mouth, constipation, urinary retention, blurred vision, tachycardia).
* **Dopamine antagonists (e.g., metoclopramide):** May reduce the efficacy of both drugs.
* **Beta-blockers:** Additive effect on heart rate may occur.
## Monitoring
* Monitor for signs of anticholinergic side effects (dry mouth, blurred vision, urinary retention, constipation, tachycardia).
* Assess for effectiveness in relieving spasms and pain.
* Monitor vital signs, particularly heart rate, if parenteral administration.
## Clinical Pearls
* Parenteral administration can be associated with a higher incidence of adverse effects compared to oral administration.
* May mask symptoms of more serious conditions; patient selection is crucial.
* Advise patients to avoid activities requiring mental alertness (e.g., driving) until they know how the medication affects them, especially with parenteral use.
* IBS symptoms: While effective for spasms, it does not address the underlying cause of IBS.
***
*This information is intended for healthcare professionals and should not be a substitute for professional medical advice. Always consult the most current prescribing information or a healthcare professional for definitive guidance.*
